Clinical Trial

Superiority Trial Evaluating Digitalized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment.

Study acronym: ePPS
Recruiting
View on ClinicalTrials.gov →
Summary
ePPS-2202 is a study designed to evaluate the benefits of a dematerialised personalised care plan (PCP) compared to standard information/PCP for patients with advanced sarcomas receiving systemic treatment. Participants will be randomised to an experimental group or a control group. Patients in the experimental group will receive the dematerialised PCP in addition to the standard PCP while patients in the control group will receive the standard PCP alone. All patients will be followed until the end of second-line treatment, the start of a new line of treatment, or until the 24-month follow-up.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-01-08; most recent amendment 2026-03-16.
Status change: Not Yet Recruiting → Recruiting 2024-05-29
Trial Details
NCT Number NCT06211257
Lead Sponsor Centre Oscar Lambret
Collaborators: Canceropôle Nord Ouest
Conditions Sarcoma Metastatic, Locally Advanced Soft Tissue Sarcoma
Enrollment 377 participants
Start Date 2024-05-29
Primary Completion 2028-07 (estimated)
Study Completion 2030-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-18